Table 1. The association of TMEM176A methylation and clinical factors in esophageal cancer.
Clinical parameter | NO. | Methylation status | P value* | |
---|---|---|---|---|
Methylated | Unmethylated | |||
n=178 | n=89 | |||
Gender | ||||
Male | 167 | 112 | 55 | p=0.964 |
Female | 100 | 66 | 34 | |
Age | ||||
≥60 | 128 | 82 | 46 | p=0.462 |
<60 | 139 | 96 | 43 | |
Differentiation | ||||
Poorly | 84 | 66 | 18 | p=0.008** |
Middle/high | 183 | 112 | 71 | |
Tumor stage | ||||
I/II | 160 | 111 | 49 | p=0.309 |
III/IV | 107 | 67 | 40 | |
Lymph node Metastasis | ||||
Positive | 177 | 112 | 65 | p=0.131 |
Negative | 90 | 66 | 24 | |
Drinking history | ||||
Yes | 66 | 46 | 20 | p=0.652 |
No | 201 | 132 | 69 | |
Family history | ||||
Yes | 113 | 79 | 34 | p=0.405 |
No | 154 | 99 | 55 | |
Smoking history | ||||
Yes | 103 | 73 | 30 | p=0.65 |
No | 164 | 105 | 59 | |
Tumor size | ||||
≥3cm | 121 | 87 | 34 | p=0.128 |
<3cm | 146 | 91 | 55 |
*p values are obtained from chi-square test and the Fisher’s exact test, significant difference, p< 0.05.